Results 21 to 30 of about 270,741 (258)

Programmed cell death in hepatic fibrosis: current and perspectives

open access: yesCell Death Discovery, 2023
The initiation, development and resolution of hepatic fibrosis are influenced by various cytokines, chemokines, damage-associated molecular patterns (DAMPs) and signaling pathways.
Ju-Lu Lu, Chuan-Xin Yu, Li-Jun Song
doaj   +1 more source

Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity

open access: yesCells, 2022
Current research proves that immune dysregulation is a common feature of coronavirus disease 2019 (COVID-19), and immune exhaustion is associated with increased disease mortality.
Paulina Niedźwiedzka-Rystwej   +8 more
doaj   +1 more source

Regulation of a Virus-Induced Lethal Disease in Tomato Revealed by LongSAGE Analysis

open access: yesMolecular Plant-Microbe Interactions, 2007
Infection of Cucumber mosaic virus (CMV) and D satellite RNA (satRNA) in tomato plants induces rapid plant death, which has caused catastrophic crop losses.
Saeed Irian   +4 more
doaj   +1 more source

Development of a Lesion-Mimic Phenotype in a Transgenic Wheat Line Overexpressing Genes for Pathogenesis-Related (PR) Proteins Is Dependent on Salicylic Acid Concentration

open access: yesMolecular Plant-Microbe Interactions, 2003
In the course of coexpressing genes for pathogenesis-related (PR) proteins for a class IV chitinase and an acidic glucanase in transgenic wheat plants, we regenerated a wheat line that developed necrotic lesions containing dead cells in the T2 and ...
Ajith Anand   +2 more
doaj   +1 more source

Programmed cell death in aging [PDF]

open access: yesAgeing Research Reviews, 2015
Programmed cell death (PCD) pathways, including apoptosis and regulated necrosis, are required for normal cell turnover and tissue homeostasis. Mis-regulation of PCD is increasingly implicated in aging and aging-related disease. During aging the cell turnover rate declines for several highly-mitotic tissues. Aging-associated disruptions in systemic and
openaire   +2 more sources

Programmed Cell Death in Cancer Cells [PDF]

open access: yesKlinicka onkologie, 2014
Resistance to programmed cell death is one of the hallmarks of cancer cells that affects the process of malignant transformation as well as response to cancer therapy. The goal of this review is to summarize recent information about programmed cell death (PCD) in healthy and cancer cells, as well as new perspectives for anticancer treatments targeting ...
E, Ondroušková, B, Vojtěšek
openaire   +2 more sources

Apoptosis: Programmed Cell Death [PDF]

open access: yesArchives of Surgery, 1998
Currently there is much interest and excitement in the understanding of how cells undergo the process of apoptosis or programmed cell death. Understanding how, why, and when cells are instructed to die may provide insight into the aging process, autoimmune syndromes, degenerative diseases, and malignant transformation.
N K, Kuan, E, Passaro
openaire   +2 more sources

Programmed Cell Death in Neurodevelopment [PDF]

open access: yesDevelopmental Cell, 2015
Programmed cell death (PCD) is an evolutionarily conserved contributor to nervous system development. In the vertebrate peripheral nervous system, PCD is the basis of the neurotrophic theory, whereby cell death results from a surplus of neurons relative to target and competition for neurotrophic factors. In addition to stochastic cell death, PCD can be
Yamaguchi, Yoshifumi, Miura, Masayuki
openaire   +2 more sources

Programmed cell death with a necrotic-like phenotype

open access: yesBiomolecular Concepts, 2013
Programmed cell death is the process by which an individual cell in a multicellular organism commits cellular ‘suicide’ to provide a long-term benefit to the organism.
Morgan Michael J., Liu Zheng-gang
doaj   +1 more source

Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report

open access: yesBMC Pulmonary Medicine, 2021
Background Immune checkpoint inhibitors have potential applications in treating various cancers but are associated with immune-related adverse events, such as inflammation, in a wide range of organs; however, allergic inflammation caused by these agents ...
Masanori Harada   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy